Overview
Craniodiaphyseal dysplasia (CDD) is an extremely rare skeletal disorder characterized by massive generalized hyperostosis and sclerosis of the skull and facial bones, along with sclerosis and hyperostosis of the diaphyses (shafts) of long bones. The condition leads to progressive thickening and distortion of the craniofacial bones, resulting in a dramatically altered facial appearance sometimes described as 'leontiasis ossea' (lion-like facies). The excessive bone growth in the skull can cause narrowing and obstruction of cranial foramina, leading to serious complications including compression of cranial nerves, which may result in facial palsy, hearing loss, visual impairment, and even blindness. Obstruction of the nasal passages and paranasal sinuses is common, causing breathing difficulties. Increased intracranial pressure may also develop due to reduced intracranial space. The condition typically manifests in early infancy or childhood, with progressive facial distortion and neurological complications worsening over time. Affected individuals may also exhibit wide nasal bridge, hypertelorism (widely spaced eyes), and mandibular enlargement. The long bones show cortical thickening and diaphyseal sclerosis, though the epiphyses are generally spared. Intellectual development may be affected in some cases due to increased intracranial pressure. There is currently no cure for craniodiaphyseal dysplasia. Treatment is primarily supportive and symptomatic. Surgical intervention may be attempted to decompress cranial nerves, relieve nasal obstruction, or reduce intracranial pressure, but bone regrowth after surgery is common and outcomes are often limited. Repeated surgical procedures may be necessary. The prognosis is generally poor, with many patients experiencing significant morbidity from progressive cranial nerve compression and potential life-threatening complications. Both autosomal dominant and autosomal recessive forms have been described, with the autosomal dominant form being more commonly reported in the literature.
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Infantile
Begins in infancy, roughly 1 month to 2 years old
Treatments
No FDA-approved treatments are currently listed for Craniodiaphyseal dysplasia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Craniodiaphyseal dysplasia at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Craniodiaphyseal dysplasia.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Craniodiaphyseal dysplasia.
Community
No community posts yet. Be the first to share your experience with Craniodiaphyseal dysplasia.
Start the conversation →Latest news about Craniodiaphyseal dysplasia
No recent news articles for Craniodiaphyseal dysplasia.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Craniodiaphyseal dysplasia
What is Craniodiaphyseal dysplasia?
Craniodiaphyseal dysplasia (CDD) is an extremely rare skeletal disorder characterized by massive generalized hyperostosis and sclerosis of the skull and facial bones, along with sclerosis and hyperostosis of the diaphyses (shafts) of long bones. The condition leads to progressive thickening and distortion of the craniofacial bones, resulting in a dramatically altered facial appearance sometimes described as 'leontiasis ossea' (lion-like facies). The excessive bone growth in the skull can cause narrowing and obstruction of cranial foramina, leading to serious complications including compression
At what age does Craniodiaphyseal dysplasia typically begin?
Typical onset of Craniodiaphyseal dysplasia is infantile. Age of onset can vary across affected individuals.